Combined with inflammatory factors CRP and IL-6, it has important clinical value in diagnosing the severity and prognosis of cerebral infarction and is expected to be a biomarker for diagnosing and predicting the progression and prognosis of ACI. Here, CRP is linked to cerebral infarction.